Detailed mechanistic studies are required to characterise and further investigate how the Mecp2 mutations affect Plexin B1 expression in glial cells, and effects of SEMA4D on neuronal function and phenotype, as well as the impact on peripheral immune responses that can also influence neuropathology of Rett syndrome. Here, MECP2 is linked to Rett syndrome.